Pharma

Your Article Summary

See Latest Articles

Watson Pharmaceuticals Receives FDA Approval for Generic PLAN B for Over-the-Counter Use
Watson Pharmaceuticals, 08/31/09

Watson Pharmaceuticals, Inc. , a leading specialty pharmaceutical company, announced that its subsidiary, Watson Laboratories, Inc., has received approval from the United States Food and Drug Administration on its Abbreviated New Drug Application for Levonorgestrel Tablets, 0.75 mg for over–the–counter use in women ages 17 and above, as well as for prescription use in women under the age of 17. Levonorgestrel Tablets, 0.75 mg is the generic equivalent to Duramed Pharmaceuticals' PLAN B, which is indicated for the prevention of pregnancy following unprotected intercourse or contraceptive failure.

Today in Drug/Product Approvals...keeping you current

Receive free subspecialty "5-minute updates" via email

FDA Approves Gardasil to Prevent Genital Warts in Males. Agency Also Approves Bivalent HPV Vaccine for Girls, Young Women
American Family Physician, 10/27/09

Novartis receives FDA approval for Valturna®, a single-pill combination of valsartan and aliskiren, to treat high blood pressure
Novartis, 09/18/09

Salix Receives FDA Marketing Approval for Metozolv
Salix Pharmaceuticals, 09/09/09

See All of Drug/Product Approvals